EP1631302A4 - Migraine remedy - Google Patents

Migraine remedy

Info

Publication number
EP1631302A4
EP1631302A4 EP04734446A EP04734446A EP1631302A4 EP 1631302 A4 EP1631302 A4 EP 1631302A4 EP 04734446 A EP04734446 A EP 04734446A EP 04734446 A EP04734446 A EP 04734446A EP 1631302 A4 EP1631302 A4 EP 1631302A4
Authority
EP
European Patent Office
Prior art keywords
migraine remedy
migraine
remedy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04734446A
Other languages
German (de)
French (fr)
Other versions
EP1631302A1 (en
Inventor
Larry Ellsworth Stenswick
Sirichai Chayasirisobhon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MigCo Ltd
Original Assignee
MigCo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MigCo Ltd filed Critical MigCo Ltd
Publication of EP1631302A1 publication Critical patent/EP1631302A1/en
Publication of EP1631302A4 publication Critical patent/EP1631302A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/15Pinaceae (Pine family), e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrane Compounds (AREA)
EP04734446A 2003-05-23 2004-05-21 Migraine remedy Withdrawn EP1631302A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ526098A NZ526098A (en) 2003-05-23 2003-05-23 Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine
PCT/NZ2004/000095 WO2004103411A1 (en) 2003-05-23 2004-05-21 Migraine remedy

Publications (2)

Publication Number Publication Date
EP1631302A1 EP1631302A1 (en) 2006-03-08
EP1631302A4 true EP1631302A4 (en) 2010-07-07

Family

ID=33476120

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04734446A Withdrawn EP1631302A4 (en) 2003-05-23 2004-05-21 Migraine remedy

Country Status (8)

Country Link
EP (1) EP1631302A4 (en)
JP (1) JP2007501856A (en)
CN (1) CN1901928B (en)
AU (2) AU2004241889B2 (en)
CA (1) CA2526631A1 (en)
MX (1) MXPA05012636A (en)
NZ (1) NZ526098A (en)
WO (1) WO2004103411A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005005275A1 (en) * 2005-02-04 2006-08-10 Peter Heger Use of a hydroxystilbene-containing active substance combination containing resveratrol and piceatannol precursors, to prevent and/or treat diseases caused by increased serum interleukin-6 level e.g. depression
JP2006298808A (en) * 2005-04-19 2006-11-02 Hayashibara Biochem Lab Inc Pain sensation moderator
US20070059392A1 (en) * 2005-09-15 2007-03-15 Peter Rohdewald COX inhibitor
JP5430891B2 (en) * 2007-10-04 2014-03-05 森永製菓株式会社 Melanin production inhibitor
WO2014050840A1 (en) * 2012-09-28 2014-04-03 サントリーホールディングス株式会社 Monomeric proanthocyanidin-removed plant extract
CN116999563A (en) * 2017-05-10 2023-11-07 艾克萨姆治疗公司 Pharmaceutical composition comprising meloxicam

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698360A (en) * 1985-04-09 1987-10-06 Societe Civile D'investigations Pharmacologiques D'aquitaine Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
WO1997044407A1 (en) * 1996-05-23 1997-11-27 Ian Alexander Gilmour Process for extraction of proanthocyanidins from botanical material
FR2775600A1 (en) * 1998-03-05 1999-09-10 Ravi Shrivastava Medicaments or nutritional supplements for treating disorders associated with deregulation of serotonin receptors, especially headache, migraine, depression, memory disorders and anxiety
WO2002020028A2 (en) * 2000-09-06 2002-03-14 Braswell A Glenn Method and composition for enhancing vision
US6391310B1 (en) * 1996-03-13 2002-05-21 Archer Daniels Midland Company Method of preparing and using isoflavones for the treatment of neurological symptoms

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5939076A (en) * 1997-11-12 1999-08-17 Allocca Techical, Inc. Composition and method for treating or alleviating migraine headaches
EP1082122A4 (en) * 1998-05-27 2003-04-09 Sherwood L Gorbach Isoflavonoids for treatment and prevention of migraine headaches
IT1313862B1 (en) * 1999-11-11 2002-09-24 Solvay EXTREMITY BOX OF AN ELECTRODIALIZER, ELECTRODIALIZER THAT INCLUDES SUCH EXTREMITY BOX AND PROCEDURE OF
US20040077556A1 (en) * 2002-04-22 2004-04-22 Robert Chinery Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals
MXPA05001051A (en) * 2002-08-06 2005-04-08 The Quigley Corp Anti-microbial compositions and methods of using same.
CA2407429C (en) * 2002-10-16 2007-02-20 Celt Corporation Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698360A (en) * 1985-04-09 1987-10-06 Societe Civile D'investigations Pharmacologiques D'aquitaine Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
US6391310B1 (en) * 1996-03-13 2002-05-21 Archer Daniels Midland Company Method of preparing and using isoflavones for the treatment of neurological symptoms
WO1997044407A1 (en) * 1996-05-23 1997-11-27 Ian Alexander Gilmour Process for extraction of proanthocyanidins from botanical material
FR2775600A1 (en) * 1998-03-05 1999-09-10 Ravi Shrivastava Medicaments or nutritional supplements for treating disorders associated with deregulation of serotonin receptors, especially headache, migraine, depression, memory disorders and anxiety
WO2002020028A2 (en) * 2000-09-06 2002-03-14 Braswell A Glenn Method and composition for enhancing vision

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHAYASIRISOBHON ET AL: "PO29-FR-11 Use of a pine bark extract and vitamin C combination product as therapy for migraine", JOURNAL OF NEUROLOGICAL SCIENCES, ELSEVIER SCIENTIFIC PUBLISHING CO, AMSTERDAM, NL LNKD- DOI:10.1016/S0022-510X(09)71199-2, vol. 285, 1 October 2009 (2009-10-01), pages S315, XP026758276, ISSN: 0022-510X, [retrieved on 20091001] *
CHAYASIRISOBHON S: "Use of a pine bark extract and antioxidant vitamin combination product as therapy for migraine in patients refractory to pharmacologic medication", HEADACHE 200605 US LNKD- DOI:10.1111/J.1526-4610.2006.00454.X, vol. 46, no. 5, May 2006 (2006-05-01), pages 788 - 793, XP002582418 *
KOLODZIEJ H: "OLIGOMERIC FLAVAN-3-OLS FROM MEDICINAL WILLOW BARK", PHYTOCHEMISTRY (OXFORD), vol. 29, no. 3, 1990, pages 955 - 960, XP002582429, ISSN: 0031-9422 *
See also references of WO2004103411A1 *

Also Published As

Publication number Publication date
CN1901928B (en) 2012-06-20
CA2526631A1 (en) 2004-12-02
AU2010212521A1 (en) 2010-09-16
WO2004103411A1 (en) 2004-12-02
AU2004241889B2 (en) 2010-09-16
AU2004241889A1 (en) 2004-12-02
MXPA05012636A (en) 2006-05-25
EP1631302A1 (en) 2006-03-08
JP2007501856A (en) 2007-02-01
CN1901928A (en) 2007-01-24
NZ526098A (en) 2005-10-28

Similar Documents

Publication Publication Date Title
TWI372050B (en) (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
DE602004023400D1 (en) Lies
DE502004011703D1 (en) N-heterocyclyl-phenylsubstituierte cyclische ketoenole
AU314014S (en) Sink
DE502004009243D1 (en) Spirocyclische cyclohexan-derivate
AU155161S (en) Case
HK1145463A1 (en) Remedy
DE502004003476D1 (en) Standfuss
DE502004006683D1 (en) Injection-locked-oscillator-schaltkreis
DE502004011852D1 (en) Nspritzventil
DE502004004146D1 (en) Pyrazolverbindungen
DE112004002769D2 (en) Schienengeführtes transportsystem
DE502004011343D1 (en) Rotorspinnmaschine
DE602004012262D1 (en) Benzimidazolonverbindung
DE502004012153D1 (en) Rotorspinnmaschine
EP1631302A4 (en) Migraine remedy
DE10394343D2 (en) Berührungslose biometrische erkennung
AU155596S (en) Case
AU154774S (en) Sink
DE602004009041D1 (en) Hydroxytetrahydronaphthalenylharnstoffderivate
AU156879S (en) Sink
DE602004008281D1 (en) Avermectin-b1-monosaccharidderivative
AU156878S (en) Sink
GB0322675D0 (en) Fine preventer
AU2834P (en) Baltinblus Gaura lindheimeri

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051214

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20100604

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20131203